VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...
In this webinar, learn how advanced nanoparticle characterization improves formulation stability, product quality, and ...
Process characterization and viral clearance validation are pivotal studies in biopharmaceutical manufacturing, particularly for monoclonal antibodies (mAbs) produced in mammalian systems, which carry ...
BILTHOVEN, The Netherlands, June 08, 2026 (GLOBE NEWSWIRE) -- Intravacc, a leading global contract development and manufacturing organization specializing in vaccine and biologics development and ...
The stability of lisinopril in an extemporaneously prepared suspension stored at or below 25 °C for 28 days under ambient light exposure was studied. A formulation of 1-mg/mL oral suspension was ...
Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit - the largest global meeting dedicated purely to LNPs. The official event guide is your ...
Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...
VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results